Ascendis Pharma A (ASND) EBITDA Margin (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) EBITDA Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 769.00 |
| Dec 31, 2025 | -277.00 |
| Sep 30, 2025 | 3,865.00 |
| Jun 30, 2025 | 6,972.00 |
| Mar 31, 2025 | -12.37 Mn |
| Dec 31, 2024 | 12.37 Mn |
| Sep 30, 2024 | 20,290.00 |
| Jun 30, 2024 | -31,893.00 |
| Mar 31, 2024 | -3,916.00 |
| Dec 31, 2023 | 26,772.00 |
| Sep 30, 2023 | 1,735.00 |
| Jun 30, 2023 | 13,060.00 |
| Mar 31, 2023 | 21,598.00 |
| Dec 31, 2022 | 30,134.00 |
| Sep 30, 2022 | 135,836.00 |
| Jun 30, 2022 | -42,840.00 |
| Mar 31, 2022 | -174,435.00 |
| Dec 31, 2021 | 857,836.00 |
| Sep 30, 2021 | 280,061.00 |
| Jun 30, 2021 | 519,943.00 |